Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06093724
Other study ID # 87RI23_005-TRANSPELV
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 21, 2023
Est. completion date June 15, 2026

Study information

Verified date March 2023
Source University Hospital, Limoges
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The research consists of adding to the usual MtF transgender patient undergoing vaginoplasty care course, static and dynamic perineo-pelvic MRI before, and at 6 and 24 months. The aim is to assess perineo-pelvic static's evolution, based on the appearance of a rectocele.


Description:

Transgender people are estimated to be about 0,3 to 1 % of general population, and MtF reassignment surgery is raising. Vaginoplasty is not always necessary, but is usually an important step into gender transition. In France, surgical techniques' gold-standard is the peno-scrotal inversion vaginoplasty, which consists in the creation of a neo-vagina with peno-scrotal skin graft. Genital, perineum and pelvic anatomy is modified, without knowing in advance about functional and aesthetic results. MRI is the best way to assess soft tissue anatomy in the pelvis. Though, only few studies have assessed pre and post-operative imaging in patients undergoing vaginoplasty, and none have been prospective, neither have assessed the risk of rectocele. The issue is legitimate, because the surgery weakens elements of pelvic fixity, and fixity issues can appear secondarily. MtF transgender patients operated for a vaginoplasty are undergoing static and dynamic MRI before the surgery, at 6 and at 24 post-operative months. We look after the appearance of a rectocele and it's evolution in time, as criteria for the assessment of pelvic fixity. Follow-up is composed of several consultations including post-operative MRI, but also clinical measures, census of post-operative issues, and questionnaires for the assessment of secondary objectives.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date June 15, 2026
Est. primary completion date August 21, 2024
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient over 18 years old - Patient admitted in urology ward at Limoges' University Hospital for MtF sexual reassignment surgery by vaginoplasty - Patient affiliated or benefitting from a social security system - Patient free, informed, written and signed consent Exclusion Criteria: - Patient admitted for vulvoplasty surgery - Patient admitted for second vaginoplasty surgical gesture - Contraindication of realizing an MRI

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Static and dynamic perineo-pelvic MRI
Static and dynamic perineo-pelvic MRI before surgery, and at 6 and 24 months after surgery.

Locations

Country Name City State
France University Hospital, Limoges Limoges

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Limoges

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement comparison of the rectal bulge's size and classification Comparison and classification by pre-operative and post-operative MRI 6 months and 24 months
Secondary Rectocele Describe the rectocele's mean size and it's progress 6 months and 24 months
Secondary Rectocele Describe the rectocele size's progress by class 6 months and 24 months
Secondary Reproducibility in the rectocele's measurement Evaluate intra and inter-operator reproducibility in the rectocele's measurement 6 months and 24 months
Secondary Symptomatology pelvic fixity Evaluate correlation between symptomatology and the rectocele assessment 6 months and 24 months
Secondary Factors pelvic fixity Evaluate correlation between factors and the rectocele assessment 6 months and 24 months
Secondary Skin-graft's neo-vagina's sizes Evaluate correlation between the skin-graft's size in cm² and the neo-vagina's sizes (lenght, width) in cm 6 months and 24 months
Secondary Imaging measures Evaluate modifications of imaging measures size in cm² and the neo-vagina's sizes (lenght, width) in cm 6 months and 24 months
Secondary Urinary quality Evaluate evolution of unrinary quality of life with Urinary Symptom Profile (USP) score, from 0 (best) to 39 (worst) 6 months and 24 months
Secondary Self-imaging Evaluate evolution of self-imaging with Body Image (BI-1) score, from 30 (no change) to 150 (change) ; and Female Genital Self-Image Scale (FGSIS) score, from 7 (worst) to 28 (best) 6 months and 24 months
Secondary Sexual quality Evaluate evolution of sexual quality of life with Operated Male-to-Female Sexual Function Index (OmtFSFI) score, from 18 (best) to 72 (worst) 6 months and 24 months
Secondary Post-operative issues Epidemiologic census of post-operative issues Instantly, 6 months and 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT04977765 - Cardiometabolic Health in Transgender Males
Recruiting NCT06074796 - The Determinants of Fertility Preservation in TRANSgender Patients.
Completed NCT04454970 - Safe Access for Bladder Entry in Transgender Men Following Penile Reconstruction N/A
Completed NCT04708600 - Effectiveness of Speech Therapy in Trans Women. N/A
Terminated NCT04551144 - Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
Completed NCT04545450 - Effects of Testosterone Plus Dutasteride or Placebo on Muscle Strength, Body Composition and Metabolism in Transmen Phase 3
Recruiting NCT05663892 - Drug-Drug Interaction Study in Trans Women Living With HIV Phase 4
Completed NCT05666102 - Transgender Men's Perspectives on HIV Risk and HIV Prevention Interventions N/A
Recruiting NCT04838249 - Effects of Cross-sex Hormone Therapy on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System
Recruiting NCT05883553 - Epithesis Versus Prosthesis in Post-phalloplasty Transgender Patients. N/A
Not yet recruiting NCT04154358 - Implementing HPV DNA Self-Collection to Increase Rates of Cervical Cancer Screening in Transgender Men N/A
Recruiting NCT04254354 - Transgender Men, Non-binary Persons and Testosterone Treatment BODY IDENTITY CLINIC
Completed NCT04969003 - Reducing Transphobia Among Adolescents Through a Brief Video Intervention N/A
Completed NCT06149065 - Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study
Terminated NCT04275310 - Microeconomic Intervention to Reduce HIV Transmission in Economically Disadvantaged Transgender Women N/A
Not yet recruiting NCT05415930 - Evaluation of an Adaptative, Multidisciplinary, Reach-out Program, Facilitating Pre Exposition HIV Prophylaxis (PrEP) Prescription and Retention in Care, in a Group of Trans Womens (TW) at High Risk of HIV Infection.
Completed NCT04515654 - Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre: Supporting Trans Identities and Occupational Justice Through Narrative Informed Theatre N/A
Recruiting NCT05761678 - Quality of Life of Transgender People - Implementation and Monitoring of an Online Cohort (e-QoL-Trans)
Not yet recruiting NCT06218446 - Transgender Caregivers' and Patients' Representations of Parenthood as Part of a Fertility Preservation Pathway
Recruiting NCT05474768 - Expectations and Beliefs of Transgender People Regarding Hormonal Treatment